Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Julius Clinical logo — Julius Clinical manages global clinical drug trials that wil...

Julius Clinical

Julius Clinical manages global clinical drug trials that will have a major impact on medicine and make a real difference

Founded 2008 The Netherlands The Netherlands 176 employees Private Equity Health Care, Pharmaceutical

General Information

Company Name Julius Clinical
Founded Year 2008
Location The Netherlands The Netherlands +1
Founders / Decision Makers
Team member
Employees 176
Industries Health Care, Pharmaceutical
Funding Stage Private Equity
Social

Get notified when Julius Clinical moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Julius Clinical

Julius Clinical is a health care and pharmaceutical startup founded in 2008 and headquartered in The Netherlands. The company manages global clinical drug trials with the objective of making a significant impact on medicine and people's lives, as highlighted by their slogan, "Julius Clinical manages global clinical drug trials that will have a major impact on medicine and make a real difference." The company's approach is characterized by a strong emphasis on science, flexibility, creativity, innovation, and skilled networks of investigators globally. It collaborates with leading pharmaceutical, biotech, medical device, and food companies, as well as academic investigators, to conduct clinical trials in therapeutic areas such as cardiology, diabetes, CNS, and infectious diseases. The latest investment in Julius Clinical came in the form of a Private Equity Round at 28 November 2023 from Ampersand Capital Partners. The substantial global reach and reputation of the company are facilitated by its internationally recognized academic leaders and personal links with peers worldwide. This extensive network enables the company to efficiently select high-performing sites for trials and maintain motivated investigators. In summary, Julius Clinical stands out as a company that combines scientific expertise with operational efficiency to deliver impactful results in the field of clinical trials.

Taxonomy: clinical drug trials, global reach, scientific approach, clinical development programs, pharmaceutical, biotech, medical device, academic investigators, cardiology, diabetes, CNS, infectious diseases, global reputation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round •••••• 1
Investor
28 Nov 2023

Julius Clinical Alternatives & Competitors

Julius Clinical vs
CLINEXEL
CLINEXEL India

Your Trusted Partner for Clinical Research & Pharmacovigilance

37 employees
Medical Devices, Pharmaceutical
Compare Julius Clinical vs CLINEXEL
Julius Clinical vs
SF Research Institute
SF Research Institute United States

Where Science Meets Innovation

4 employees
Education
Compare Julius Clinical vs SF Research Institute
Julius Clinical vs
LINEA System
LINEA System United States

Site Identification > Activation - Perfected

15 employees
Biotechnology
Compare Julius Clinical vs LINEA System

FAQ About Julius Clinical

Julius Clinical manages global clinical drug trials that will have a major impact on medicine and make a real difference
Julius Clinical was founded in 2008.
Julius Clinical is headquartered in The Netherlands.
Julius Clinical operates in the following industries: Health Care, Pharmaceutical.
Julius Clinical has approximately 176 employees.
Julius Clinical has completed 1 funding round. The latest funding stage is Private Equity.
Top alternatives and competitors to Julius Clinical include CLINEXEL, SF Research Institute , LINEA System, CERC (Cardiovascular European Research Center), GreenLight Clinical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Julius Clinical and CLINEXEL are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Julius Clinical and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy